Assembly Biosciences
ASMB
91 hedge funds and large institutions have $105M invested in Assembly Biosciences in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 30 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.64% less ownership
Funds ownership: 6.26% → 5.62% (-0.64%)
15% less funds holding
Funds holding: 107 → 91 (-16)
17% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 36
21% less capital invested
Capital invested by funds: $134M → $105M (-$28.5M)
21% less call options, than puts
Call options by funds: $1.17M | Put options by funds: $1.49M
53% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.34M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.15M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.06M |
| 4 |
Millennium Management
New York
|
+$1.84M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$916K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$5.7M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.83M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$1.57M |
| 4 |
PP
PDT Partners
New York
|
-$1.26M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.11M |
ASMB Hedge Fund Activity: Q2 2021 in Review
91 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2021, worth a combined $105M — down 21% from $134M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of ASMB and 14 opened new positions — a net loss of 16 holders — while 36 trimmed existing stakes and 30 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $2.34M. The largest seller was BlackRock, cutting an estimated $5.7M.
- 91 institutional investors held Assembly Biosciences (ASMB) as of Q2 2021, down from 107 in Q1 2021.
- Funds reported $105M of Assembly Biosciences stock for Q2 2021, down 21% quarter-over-quarter.
- 14 funds opened new Assembly Biosciences positions in Q2 2021 and 30 closed out, a net change of -16 holders.
- The largest Assembly Biosciences buyer in Q2 2021 was Baker Bros. Advisors, an estimated $2.34M added.
- The largest Assembly Biosciences seller in Q2 2021 was BlackRock, an estimated $5.7M sold.
Based on aggregated 13F filings for Q2 2021.